Literature DB >> 19002745

Expression of GABA(B) receptors is altered in brains of subjects with autism.

S Hossein Fatemi1, Timothy D Folsom, Teri J Reutiman, Paul D Thuras.   

Abstract

Autism is a neurodevelopmental disorder that is often comorbid with seizures. Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in brain. GABA(B) receptors play an important role in maintaining excitatory-inhibitory balance in brain and alterations may lead to seizures. We compared levels of GABA(B) receptor subunits GABA(B) receptor 1 (GABBR1) and GABA(B) receptor 2 (GABBR2) in cerebellum, Brodmann's area 9 (BA9), and BA40 of subjects with autism and matched controls. Levels of GABBR1 were significantly decreased in BA9, BA40, and cerebellum, while GABBR2 was significantly reduced in the cerebellum. The presence of seizure disorder did not have a significant impact on the observed reductions in GABA(B) receptor subunit expression. Decreases in GABA(B) receptor subunits may help explain the presence of seizures that are often comorbid with autism, as well as cognitive difficulties prevalent in autism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19002745      PMCID: PMC2732344          DOI: 10.1007/s12311-008-0075-3

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  19 in total

Review 1.  Neurochemical and molecular pharmacological aspects of the GABA(B) receptor.

Authors:  K Kuriyama; M Hirouchi; H Kimura
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

2.  Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)).

Authors:  V Schuler; C Lüscher; C Blanchet; N Klix; G Sansig; K Klebs; M Schmutz; J Heid; C Gentry; L Urban; A Fox; W Spooren; A L Jaton; J Vigouret; M Pozza; P H Kelly; J Mosbacher; W Froestl; E Käslin; R Korn; S Bischoff; K Kaupmann; H van der Putten; B Bettler
Journal:  Neuron       Date:  2001-07-19       Impact factor: 17.173

3.  Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices.

Authors:  S Hossein Fatemi; Amy R Halt; Joel M Stary; Reena Kanodia; S Charles Schulz; George R Realmuto
Journal:  Biol Psychiatry       Date:  2002-10-15       Impact factor: 13.382

4.  Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications.

Authors:  Jane Yip; Jean-Jacques Soghomonian; Gene J Blatt
Journal:  Acta Neuropathol       Date:  2007-01-18       Impact factor: 17.088

Review 5.  Epilepsy in autism.

Authors:  Roberto Tuchman; Isabelle Rapin
Journal:  Lancet Neurol       Date:  2002-10       Impact factor: 44.182

Review 6.  Significance and management of transitory cognitive impairment due to subclinical EEG discharges in children.

Authors:  C D Binnie
Journal:  Brain Dev       Date:  1993 Jan-Feb       Impact factor: 1.961

7.  Modification of GABA(B1) and GABA(B2) receptor subunits in the somatosensory cerebral cortex and thalamus of rats with absence seizures (GAERS).

Authors:  Alessandra P Princivalle; Douglas A Richards; John S Duncan; Roberto Spreafico; Norman G Bowery
Journal:  Epilepsy Res       Date:  2003 Jun-Jul       Impact factor: 3.045

8.  Up-regulation of GABA(B) receptor mRNA and protein in the hippocampus of cocaine- and lidocaine-kindled rats.

Authors:  J Li; A B Olinger; M S Dassow; M S Abel
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

9.  Rapid and long-term alterations of hippocampal GABAB receptors in a mouse model of temporal lobe epilepsy.

Authors:  Andrea Straessle; Fabienne Loup; Dimitrula Arabadzisz; Gordon V Ohning; Jean-Marc Fritschy
Journal:  Eur J Neurosci       Date:  2003-10       Impact factor: 3.386

10.  GABA(B1a), GABA(B1b) AND GABA(B2) mRNA variants expression in hippocampus resected from patients with temporal lobe epilepsy.

Authors:  A P Princivalle; J S Duncan; M Thom; N G Bowery
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

View more
  97 in total

1.  Subchronic administration and combination metabotropic glutamate and GABAB receptor drug therapy in fragile X syndrome.

Authors:  Laura K K Pacey; Sujeenthar Tharmalingam; David R Hampson
Journal:  J Pharmacol Exp Ther       Date:  2011-06-02       Impact factor: 4.030

Review 2.  GABA-based evaluation of neurologic conditions: MR spectroscopy.

Authors:  L M Levy; A J Degnan
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-19       Impact factor: 3.825

3.  Abnormal modulation of corticospinal excitability in adults with Asperger's syndrome.

Authors:  Lindsay Oberman; Mark Eldaief; Shirley Fecteau; Fritz Ifert-Miller; Jose Maria Tormos; Alvaro Pascual-Leone
Journal:  Eur J Neurosci       Date:  2012-06-28       Impact factor: 3.386

4.  In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism.

Authors:  Silvia Bernardi; Evdokia Anagnostou; Jun Shen; Alexander Kolevzon; Joseph D Buxbaum; Eric Hollander; Patrick R Hof; Jin Fan
Journal:  Brain Res       Date:  2010-12-23       Impact factor: 3.252

Review 5.  Use of transcranial magnetic stimulation in autism spectrum disorders.

Authors:  Lindsay M Oberman; Alexander Rotenberg; Alvaro Pascual-Leone
Journal:  J Autism Dev Disord       Date:  2015-02

Review 6.  Sensory perception in autism.

Authors:  Caroline E Robertson; Simon Baron-Cohen
Journal:  Nat Rev Neurosci       Date:  2017-09-29       Impact factor: 34.870

7.  Exploring the relationship between cortical GABA concentrations, auditory gamma-band responses and development in ASD: Evidence for an altered maturational trajectory in ASD.

Authors:  Russell G Port; William Gaetz; Luke Bloy; Dah-Jyuu Wang; Lisa Blaskey; Emily S Kuschner; Susan E Levy; Edward S Brodkin; Timothy P L Roberts
Journal:  Autism Res       Date:  2016-10-01       Impact factor: 5.216

8.  Relationship among Glutamine, γ-Aminobutyric Acid, and Social Cognition in Autism Spectrum Disorders.

Authors:  David M Cochran; Elif M Sikoglu; Steven M Hodge; Richard A E Edden; Ann Foley; David N Kennedy; Constance M Moore; Jean A Frazier
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-04-28       Impact factor: 2.576

9.  Multiple pathways in prevention of immune-mediated brain disorders: Implications for the prevention of autism.

Authors:  S Hossein Fatemi
Journal:  J Neuroimmunol       Date:  2009-10-14       Impact factor: 3.478

10.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.